++
A woman in her 30s presented to her primary care physician with a 3-day history of ocular redness and watery discharge. The symptoms started in the left eye and 2 days later spread to the right eye. A coworker recently had an episode of “pink eye” and was prescribed antibiotic eye drops. On examination, visual acuity was 20/20 in each eye and diffuse redness involving the conjunctiva was present with mild eyelid swelling (Figure 111-1). Is this presentation more consistent with viral or bacterial conjunctivitis? Should antibiotic eye drops be prescribed?
++
++
Conjunctivitis is a common condition seen by general practitioners, and patients usually present for care with ocular redness and discharge. Although the incidence and prevalence of conjunctivitis are difficult to estimate, viral conjunctivitis may account for up to 20 million cases per year in the US.1 Many patients with conjunctivitis initially present to primary care physicians rather than to ophthalmologists.2,3 Conjunctivitis accounts for approximately half of all eye-related visits to general practitioners4 and an estimated one-third of eye-related emergency department visits.5
++
There is a broad differential diagnosis for the patient presenting with red eye; a detailed approach and differential diagnosis of red eye has been described elsewhere.6,7 Other common causes of red eye include allergic conjunctivitis, subconjunctival hemorrhage, and dry eye disease. More serious causes occur less frequently and include foreign body, corneal abrasion, corneal infection, scleritis, iritis, and glaucoma. Most generalist physicians can differentiate infectious conjunctivitis from other forms of red eye. For practical purposes, the presence of red eye with discharge indicates infectious conjunctivitis in the majority of cases, and requires clinicians to assess the likelihood of a viral vs a bacterial etiology. However, some clinicians may have difficulty differentiating between viral and bacterial conjunctivitis.8 For example, in a multicenter study,9 only 57 of 157 patients (32%) with clinically suspected bacterial conjunctivitis had positive bacterial cultures. As a result, many generalist physicians may prescribe topical antibiotics for patients with infectious conjunctivitis even though a large proportion of cases are caused by viruses.10-13 Excessive prescribing of antibiotics has numerous potential adverse effects, including the promotion of bacterial resistance, the possibility of toxic and allergic reactions (which may confound the clinical picture and perpetuate inflammation of the ocular surface), and increased cost.
++
A previous systematic review from 2003 reported that there was no evidence regarding whether symptoms or signs detectable by the generalist physician could help differentiate viral vs bacterial conjunctivitis.14 This Rational Clinical Examination article evaluates the relative prevalence of viral vs bacterial conjunctivitis in adults and children, and determines which clinical findings may help differentiate patients with viral conjunctivitis from those with bacterial conjunctivitis.
+++
Literature Search and Selection
++
OVID MEDLINE was searched for English-language literature published from January 1946 to March 2022 to identify articles that included series of patients with viral conjunctivitis, bacterial conjunctivitis, or both. For the search, the Medical Subject Heading conjunctivitis (focus) was used, excluding case reports, comments, and letters. All retrieved titles were screened by 2 of the authors (D.J. and D.L.), and abstracts of potentially relevant articles were further reviewed. Any article that reported on the relative frequency of viral vs bacterial conjunctivitis, or on the prevalence of various symptoms or signs in either condition was included. Articles on neonatal conjunctivitis were not included. In addition, citations of retrieved articles as well as relevant review articles were reviewed to identify further articles. Consistent with the Rational Clinical Examination series, all articles were assigned a quality score based on a modified grading system (Supplemental Box). Studies with a methodological quality level ranging from 1 to 4 used a microbiological reference standard for diagnosis, whereas studies with a quality level of 5 (the lowest quality) used a clinical reference standard for diagnosis.
+++
Data Analysis and Statistical Methods
++
The primary outcomes were analyzed using meta-analysis and included the relative prevalence of viral vs bacterial conjunctivitis and the diagnostic accuracy for various symptoms and signs associated with the 2 conditions.
++
Because the comparative frequency of viral vs bacterial conjunctivitis is known to differ in adults vs children, only studies that reported prevalence in which data could be stratified by age (adults [aged ≥ 19 years] vs children [aged 1 month-18 years]) were included in the final analysis for estimating relative prevalence of viral vs bacterial conjunctivitis. Prevalence was summarized with random-effects measures using Comprehensive Meta-Analysis version 3 (Biostat).
++
Data for diagnostic accuracy were reported as sensitivity, specificity, and likelihood ratios (LRs) for various history and examination findings. Studies included in the calculation of summary measures of the sensitivity, specificity, and LRs were required to include an undifferentiated population of patients with infectious conjunctivitis and be of Rational Clinical Examination level 1 or 2 quality. When calculating the LRs and 95% CIs from the individual studies, 0.5 was added to the 2 × 2 table cells with a value of 0.15 The results were summarized with point estimates (when evaluated in 1 study), range (when evaluated in 2 studies), and univariable random-effects measures (when evaluated in ≥ 3 studies). The univariable random-effects measures were calculated using Comprehensive Meta-Analysis. Univariable measures were used because only 1 finding was evaluated in as many as 4 studies.16 Quantitative assessment of heterogeneity was not possible because each finding was evaluated in so few studies and the use of the I2 statistic is not recommended in diagnostic test meta-analyses.17
++
As a secondary outcome, the prevalence (frequency) of various clinical findings was evaluated with a random-effects summary measure in patients with viral and bacterial conjunctivitis using studies with a methodological quality level of 1 to 4 (level 3 or 4 studies were primarily case series). The frequency of a finding in a case series of patients represents the sensitivity, but the specificity cannot be estimated. Studies with a methodological quality level of 5 were not included in the final data analysis.
++
The literature search identified 1891 articles, of which 80 included series of patients with viral or bacterial conjunctivitis (Supplemental Figure). A review of the references and citations did not yield any additional articles. Thirty-two studies9,18-49 were included in the analysis; of these, 11 had a methodological quality level of 1 or 2 (details of the included studies appear in Supplemental Table 1).21,25,26,28,29,31,33,40,41,45,47 These studies included 24 case series, 5 randomized clinical trials, 1 nonrandomized comparative trial, and 2 cohort studies.
+++
Prevalence of Viral vs Bacterial Conjunctivitis
++
A total of 5 studies (n = 1088 patients) used a microbiological reference standard, such as polymerase chain reaction or microbiological cultures, suitable for estimating the relative frequency of viral vs bacterial conjunctivitis.26,36,39,45,47 All 5 studies reported data for children and only 1 of the studies included data from an adult population.47 Among children in these 5 studies (n = 881 patients; mean age, 4.7 years [age range, 1 month-18 years]), bacterial conjunctivitis was more common than viral conjunctivitis (71% [95% CI, 38%-91%] vs 16% [95% CI, 4%-46%], P = .01). Approximately 13% of conjunctivitis cases in children were either culture negative, culture positive for Chlamydia trachomatis, or presumed to be allergic conjunctivitis. Only 1 study from Pakistan from 1992 provided data for only adults (mean age, 25.7 years) on the relative prevalence of microbiologically confirmed viral vs bacterial conjunctivitis.47 In this study, 33/207 (16%) cases of conjunctivitis were due to bacterial infection and 161/207 (78%) were from viral infection (P < .001); 13/207 (6%) were due to other causes, including herpes simplex and chlamydial conjunctivitis.
+++
Frequency of Clinical Findings
++
Most identified studies were case series (ie, level 3 or 4 studies) that were limited to either patients with viral or bacterial conjunctivitis and the frequency of a finding represented the sensitivity. The data were combined with studies that included both viral and bacterial conjunctivitis and the results were summarized to describe the frequency of findings that a clinician may evaluate (Table 111-2).
++
++
For the clinical findings evaluated in at least 3 studies among patients with viral conjunctivitis, the most frequent were conjunctival follicles (77% [95% CI, 36%-96%]; 1350 patients from 8 studies), watery discharge (77% [95% CI, 33%-96%]; 287 patients from 3 studies), eyelid swelling (59% [95% CI, 19%-90%]; 441 patients from 4 studies), bilateral eye symptoms (44% [95% CI, 33%-56%]; 943 patients from 12 studies), pharyngitis (43% [95% CI, 28%-59%]; 241 patients from 5 studies), and conjunctival hemorrhages (35% [95% CI, 16%-60%]; 1178 patients from 5 studies).
++
For the clinical findings evaluated in at least 3 studies among patients with bacterial conjunctivitis, the most frequent were the patient reported having his or her eyelids stuck together on awakening (86% [95% CI, 67%-95%]; 465 patients from 3 studies), mucopurulent ocular discharge (67% [95% CI, 48%-82%]; 991 patients from 7 studies), and bilateral eye symptoms (59% [95% CI, 44%-72%]; 1424 patients from 10 studies).
+++
Diagnostic Accuracy of Clinical Findings: Primary Analysis
++
The literature search identified 11 studies (6 with a quality level of 1 and 5 with a quality level of 2; n = 1725 participants) that reported on symptoms or signs in patients with both viral and bacterial conjunctivitis for which traditional 2 × 2 tables could be constructed for estimates of diagnostic accuracy (Table 111-3 and Supplemental Tables 2, 3, 4). The presence of pharyngitis (sensitivity range, 0.55-0.58; specificity range, 0.89-0.94; positive LR range, 5.4-9.9), preauricular lymphadenopathy (sensitivity range, 0.17-0.31; specificity range, 0.93-0.94; positive LR range, 2.5-5.6), and contact with another person with red eye (sensitivity, 0.18 [95% CI, 0.14-0.22]; specificity, 0.93 [95% CI, 0.90-0.95]; positive LR, 2.5 [95% CI, 1.6-3.7]) were the clinical findings that best discriminated viral from other forms of conjunctivitis. The presence of watery discharge and conjunctival follicles also were associated with higher positive LRs; however, the 95% CIs were wide and crossed 1.0. The absence of mucopurulent ocular discharge was associated with higher likelihood of viral conjunctivitis (sensitivity, 0.34 [95% CI, 0.27-0.42]; specificity, 0.24 [95% CI, 0.14-0.38]; positive LR, 2.7 [95% CI, 1.8-4.1]).
++
++
The clinical findings associated with a higher likelihood of bacterial conjunctivitis included mucopurulent ocular discharge (sensitivity, 0.76 [95% CI, 0.60-0.87]; specificity, 0.66 [95% CI, 0.58-0.73]; positive LR, 2.1 [95% CI, 1.7-2.6]) and otitis media (sensitivity, 0.24 [95% CI, 0.20-0.29]; specificity, 0.91 [95% CI, 0.85-0.94]; positive LR, 2.5 [95% CI, 1.5-4.4]). All studies that evaluated otitis media were in children only (514 participants from 3 studies; age range, 1 month-18 years). The likelihood of bacterial conjunctivitis also was higher when the patient did not have pharyngitis (sensitivity range, 0.06-0.11; specificity range, 0.42-0.45; positive LR range, 2.1-2.14). The LRs for the other clinical findings had wide 95% CIs that crossed 1.0 or were close to 1.0, rendering them not useful.
++
Infectious conjunctivitis is the most common ophthalmic presentation to generalist physicians. The results of this review indicated that the prevalence of bacterial conjunctivitis in children was higher than that of viral conjunctivitis, although the number of studies was small and the 95% CIs around the estimates were wide. The data on the relative causes of bacterial vs viral conjunctivitis in adults were limited but suggested that viral conjunctivitis was more common than bacterial conjunctivitis.
++
In this analysis, no single symptom or sign reliably differentiated patients with viral conjunctivitis from those with bacterial conjunctivitis. However, a number of clinical findings were associated with moderately high LRs that may assist the clinician. For example, the presence of pharyngitis, lymphadenopathy, or contact with another person with red eye were each associated with a modestly higher likelihood of viral conjunctivitis. Likewise, the presence of mucopurulent discharge and otitis media (in a child) similarly were associated with a higher likelihood of bacterial conjunctivitis.
++
The nature of discharge (watery vs mucopurulent) has been considered to be highly relevant in differentiating viral conjunctivitis from bacterial conjunctivitis. The results from the meta-analysis indicated that watery discharge was associated with higher LRs for viral conjunctivitis, whereas mucopurulent discharge was associated with bacterial conjunctivitis. However, 21% of 319 cases of viral conjunctivitis were associated with mucopurulent discharge, and 26% of 227 cases of bacterial conjunctivitis were associated with watery discharge, therefore, the nature of discharge alone was insufficient to differentiate the 2 types of conjunctivitis. In 1 study,9 patients (n = 177) who reported having had eyelids stuck together on awakening were more likely to have positive bacterial cultures (odds ratio, 11 [95% CI, 3.5-36]); however, the results of this study may have been biased by inclusion criteria requiring the presence of mucopurulent discharge, eyelids stuck together on awakening, or both.
++
In the meta-analysis, rapid immunoassay testing (Supplemental Table 4) was associated with significant positive (9.5) and negative (0.26) LRs in identifying viral conjunctivitis. However, 2 of 5 studies (which accounted for 66% of 464 patients) were sponsored by the manufacturer of the rapid immunoassay test.40,41 The other studies did not replicate the high sensitivity and specificity reported in these 2 articles.
++
A brief clinical history can aid in distinguishing viral conjunctivitis from bacterial conjunctivitis and may be helpful in ruling out other causes of red eye. Although infectious conjunctivitis may be associated with mild ocular irritation, photophobia, or both, more severe symptoms such as decreased visual acuity, pain, or severe photophobia suggest a more serious diagnosis. Important points to elicit from the patient’s history include the timing of symptom onset (ie, acute vs insidious), nature of discharge, whether eyelids are stuck together on awakening, presence of upper tract respiratory infection, and contact with another person with red eye. Contact lens wear is also important to elicit on history because patients may present with rare, atypical infections such as acanthamoeba.52
++
Many generalist physicians have limited access to the examination equipment necessary to perform an in-depth ocular examination, such as slit lamp biomicroscopy. However, inspection of the eye with the assistance of an appropriate light source can provide valuable information. For example, without a slit lamp, the clinician can evaluate the pattern of redness (monocular or binocular, diffuse or sectoral) and clarity of the cornea. Sectoral redness of the conjunctiva or sclera or whitening of the cornea are not typical of conjunctivitis. If present, the finding of preauricular lymphadenopathy can suggest viral conjunctivitis.
++
Most cases of infectious conjunctivitis are relatively mild and can be managed by the generalist physician. Many generalist physicians may feel compelled to prescribe topical antibiotics without a clear diagnosis of viral or bacterial conjunctivitis because of concern about undertreatment of bacterial conjunctivitis and potential resultant morbidity. However, most cases of bacterial conjunctivitis are self-limited, and topical antibiotics only reduce recovery time by an estimated 1 to 2 days.50 If bacterial conjunctivitis is suspected, it is prudent to prescribe antibiotics to hasten clinical recovery (even if by a short time only) and possibly reduce the risk of transmitting the infection to others. Another proposed treatment strategy is delayed prescribing in which patients are told to start antibiotic eye drops if no clinical resolution is seen after 48 hours.7
++
The clinical findings that warrant referral to ophthalmology care include conjunctivitis in a neonate, severe symptoms, decreased visual acuity, failure to respond to therapy, the presence of conjunctival membranes, and diagnostic uncertainty. A nonurgent referral to an ophthalmologist is appropriate in cases of suspected viral conjunctivitis to examine for herpes-related conjunctivitis or for late complications such as corneal infiltrates. If the clinician is uncertain of the diagnosis, referral to ophthalmology care is warranted in preference to indiscriminate administration of antibiotic eye drops.
++
This review has several limitations. First, the meta-analysis was limited by a relatively small number of studies with a methodological quality level of 1 or 2 that included both patients with viral conjunctivitis and those with bacterial conjunctivitis for which 2 × 2 tables could be created. As such, the frequency of each clinical finding is reported for the 2 conditions to assist the clinician in gauging the diagnostic utility of a given finding. For example, the positive LR range in the study for conjunctival follicles in identifying viral conjunctivitis (based on a sample of only 120 patients from a single level 1 study and a single level 2 study) was 0.88 to 3.1; however, this finding was reported in 77% of patients with viral conjunctivitis vs 32% with bacterial conjunctivitis based on a larger number of patients in studies of with a quality level of 1 to 4.25,45
++
Second, considering viral conjunctivitis or even adenoviral conjunctivitis as a single clinical entity is difficult. Even though patients with viral conjunctivitis will not benefit from antibiotics, a diverse group of viruses may result in similar yet varied presentations of conjunctivitis. For example, many serotypes of adenovirus have been reported to cause outbreaks of conjunctivitis, each with varied clinical presentations. The literature may not equally represent all adenovirus serotypes. It is known that serotypes of adenovirus vary across region54 and change from year to year.51,53 In addition, several studies included in the meta-analysis were based on older studies (some > 10 years old) and may not necessarily represent the etiologies of infectious conjunctivitis in 2022.
++
Third, the meta-analysis only investigated single symptoms or signs of bacterial vs viral conjunctivitis. It is unknown whether combinations of findings could produce a more accurate prediction model such as those used for some other conditions (eg, criteria for identifying streptococcal pharyngitis).55
++
On further questioning, the patient also reported mild sore throat (positive LR range for viral conjunctivitis, 5.4-9.9) and that her eyelids were not stuck together on awakening (positive LR for viral conjunctivitis, 3.5); no preauricular nodes were palpable on examination (positive LR range for viral conjunctivitis, 0.73-0.89). The findings were most consistent with viral conjunctivitis. The patient was disappointed to not be receiving a prescription for antibiotic eye drops, but was educated about the likelihood of a viral infection and agreed to try over-the-counter eye drops and cold compresses for comfort. She was instructed to limit spread to household members by washing hands thoroughly and not sharing towels. She also was instructed to call back if redness and discharge were not improving within 48 hours to 72 hours.
+++
Conclusion: Clinical Bottom Line
++
In this review, bacterial conjunctivitis was more common than viral conjunctivitis in children and viral conjunctivitis was more common than bacterial conjunctivitis in adults, although the prevalence estimates were based on limited evidence. Symptoms and signs associated with a higher likelihood of viral conjunctivitis in adults and children included concomitant pharyngitis, an enlarged preauricular node, and contact with another person with red eye, and signs associated with a higher likelihood of bacterial conjunctivitis included the presence of mucopurulent discharge and otitis media, but no single symptom or sign differentiated the 2 conditions with high certainty.
++
The following disclosures were reported at the time this original article was first published in JAMA.
++
Conflict of Interest Disclosures: Dr Simel reported receiving nonfinancial support from the Veterans Health Administration during the conduct of the study and receiving personal fees from JAMAevidence outside the submitted work. No other disclosures were reported.
++
Funding/Support: Dr Simel’s work was supported by the Durham Center of Innovation to Accelerate Discovery and Practice Transformation at the Durham VA Health Care System.
++
Role of the Funder/Sponsor: The funder/sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
++
Disclaimer: Dr Simel is Associate Editor of JAMA, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance.
++
Additional Contributions: We thank Stephanie Baxter, MD (Queen’s University), Isabella Ircher, PhD (Queen’s University), Kelly Muir, MD (Durham VA Health Care System and Duke University), and William Clayton Bordley, MD (Duke University), for their advice and expertise in manuscript preparation. These contributors were not financially compensated for their contributions.
1. +
Garcia-Zalisnak
D, Rapuano
C, Sheppard
JD, Davis
AR. Adenovirus ocular infections:
prevalence, pathology, pitfalls, and practical pointers.
Eye Contact Lens. 2018;44(suppl 1):S1–S7. Medline:29664772 doi:10.1097/ICL.0000000000000226
2. +
Kaufman
HE. Adenovirus advances: new diagnostic and therapeutic options.
Curr Opin Ophthalmol. 2011;22(4):290–293. Medline:21537185 doi:10.1097/
ICU.0b013e3283477cb5
3. +
Keen
M, Thompson
M. Treatment of acute conjunctivitis in the United States and evidence of antibiotic overuse: isolated issue or a systematic problem? Ophthalmology. 2017;124(8):1096–1098. Medline:28734327 doi:10.1016/j.ophtha.2017.05.029
4. +
Channa
R, Zafar
SN, Canner
JK, Haring
RS, Schneider
EB, Friedman
DS. Epidemiology of eye-related emergency department visits. JAMA Ophthalmol. 2016;134(3):312–319. Medline:26821577 doi:10.1001/jamaophthalmol.2015.5778
5. +
Shekhawat
NS, Shtein
RM, Blachley
TS, Stein
JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology. 2017;124(8):1099–1107. Medline:28624168 doi:10.1016/j.ophtha.2017.04.034
6. +
Azari
AA, Barney
NP. Conjunctivitis: a systematic review of diagnosis and treatment. Published correction appears in
JAMA. 2014;311(1):95.
JAMA[JAMA and JAMA Network Journals Full Text]. 2013;310(16):1721–1729. Medline:24150468 doi:10.1001/jama.2013.280318
7. +
Visscher
KL, Hutnik
CM, Thomas
M. Evidence-based treatment of acute infective conjunctivitis: breaking the cycle of antibiotic prescribing.
Can Fam Physician. 2009;55(11):1071–1075. Medline:19910590
[PubMed: 19910590]
8. +
O’Brien
TP, Jeng
BH, McDonald
M, Raizman
MB. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009;25(8):1953–1961. Medline:19552618 doi:10.1185/03007990903038269
9. +
Rietveld
RP, ter Riet
G, Bindels
PJ, Sloos
JH, van Weert
HC. Predicting bacterial cause in infectious conjunctivitis:
cohort study on informativeness of combinations of signs and symptoms.
BMJ. 2004;329(7459):206–210. Medline:15201195 doi:10.1136/bmj.38128.631319.AE
10. +
Anderson
DF, Sullivan
PM, Luff
AJ, Elkington
AR. Direct ophthalmoscopy versus slit lamp biomicroscopy in diagnosis of the acute red eye. J R Soc Med. 1998;91(3):127–128. Medline:9659322 doi:10.1177/014107689809100303
11. +
Everitt
HA, Little
PS, Smith
PW. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ. 2006;333(7563):321. Medline:16847013 doi:10.1136/bmj.38891.551088.7C
12. +
Lohr
JA. Treatment of conjunctivitis in infants and children. Pediatr Ann. 1993;22(6):359–364. Medline:8414689 doi:10.3928/0090-4481-19930601-07
13. +
Everitt
H, Little
P. How do GPs diagnose and manage acute infective conjunctivitis? a GP
survey.
Fam Pract. 2002;19(6):658–660. Medline:12429670 doi:10.1093/fampra/19.6.658
14. +
Rietveld
RP, van Weert
HC, ter Riet
G, Bindels
PJ. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BMJ. 2003;327(7418):789. Medline:14525879 doi:10.1136/bmj.327.7418.789
15. +
Hasselblad
V, Hedges
LV.
Meta-analysis of screening and diagnostic tests.
Psychol Bull. 1995;117(1):167–178. Medline:7870860 doi:10.1037/0033-2909.117.1.167
16. +
Simel
DL, Bossuyt
PM. Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. J Clin Epidemiol. 2009;62(12):1292–1300. Medline:19447007 doi:10.1016/j.jclinepi.2009.02.007
17. +
Macaskill
P. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. Cochrane Collaboration; 2010.
18. +
Akçay
E, Çarhan
A, Hondur
G,
et al. Molecular identification of viral agents associated with acute conjunctivitis: a prospective controlled study. Braz J Infect Dis. 2017;21(4):391–395. Medline:28535396 doi:10.1016/j.bjid.2017.03.016
19. +
Aoki
K, Kaneko
H, Kitaichi
N, Ohguchi
T, Tagawa
Y, Ohno
S. Clinical features of adenoviral conjunctivitis at the early stage of infection. Jpn J Ophthalmol. 2011;55(1):11–15. Medline:21331686 doi:10.1007/s10384-010-0894-x
20. +
Balasopoulou
A, Κokkinos
P, Pagoulatos
D,
et al. Α molecular epidemiological analysis of adenoviruses from excess conjunctivitis cases. BMC Ophthalmol. 2017;17(1):51. Medline:28438142 doi:10.1186/s12886-017-0447-x
21. +
Barbosa Junior
JB, Regatieri
CVS, de Paiva
TM,
et al. Adenovirus conjunctivitis diagnosis using RPS adenodetector. Published in Portuguese. Arq Bras Oftalmol. 2007;70(3):441–444. Medline:17768550 doi:10.1590/S0004-27492007000300010
22. +
Butt
AL, Chodosh
J. Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea. 2006;25(2):199–202. Medline:16371782 doi:10.1097/01.ico.0000170693.13326.fb
23. +
Buznach
N, Dagan
R, Greenberg
D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24(9):823–828. Medline:16148850 doi:10.1097/01.inf.0000178066.24569.98
24. +
Chang
CH, Lin
KH, Sheu
MM, Huang
WL, Wang
HZ, Chen
CW. The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan. Graefes Arch Clin Exp Ophthalmol. 2003;241(7):554–560. Medline:12768288 doi:10.1007/s00417-003-0680-2
25. +
Fitch
CP, Rapoza
PA, Owens
S,
et al. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology. 1989;96(8):1215–1220. Medline:2797725 doi:10.1016/S0161-6420(89)32749-7
26. +
Gigliotti
F, Williams
WT, Hayden
FG,
et al. Etiology of acute conjunctivitis in children. J Pediatr. 1981;98(4):531–536. Medline:6970802 doi:10.1016/S0022-3476(81)80754-8
27. +
Granet
DB, Dorfman
M, Stroman
D, Cockrum
P. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus. 2008;45(6):340–349. Medline:19043945 doi:10.3928/01913913-20081101-07
28. +
Holtz
KK, Townsend
KR, Furst
JW,
et al. An assessment of the AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis and its effect on antibiotic stewardship. Mayo Clin Proc Innov Qual Outcomes. 2017;1(2):170–175. Medline:30225413 doi:10.1016/j.mayocpiqo.2017.06.001
29. +
Kam
KY, Ong
HS, Bunce
C, Ogunbowale
L, Verma
S.
Sensitivity and
specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study.
Br J Ophthalmol. 2015;99(9):1186–1189. Medline:25824258 doi:10.1136/bjophthalmol-2014-306508
30. +
Li
J, Lu
X, Jiang
B,
et al. Adenovirus-associated acute conjunctivitis in Beijing, China, 2011-2013. BMC Infect Dis. 2018;18(1):135. Medline:29558885 doi:10.1186/s12879-018-3014-z
31. +
Liang
Q, Lu
X, Wang
M, Tian
L, Labbé
A, Hu
A. Study of infectious conjunctivitis among children in rural areas of Qinghai province. Sci China Life Sci. 2016;59(6):548–554. Medline:27225258 doi:10.1007/s11427-016-5058-x
32. +
Lyra
AF, Bastos
LC, Lima
RC, Maranhão
LdeV, Arantes
TE. Artificial tears alone versus 0.45% ketorolac tromethamine with artificial tears for the treatment of acute viral conjunctivitis. Arq Bras Oftalmol. 2014;77(2):99–102. Medline:25076474 doi:10.5935/0004-2749.20140025
34. +
Nayak
N, Gupta
SK, Murthy
GV, Satpathy
G, Mohanty
S. Community-based investigation of an outbreak of acute viral conjunctivitis in urban slums. Trop Med Int Health. 1996;1(5):667–671. Medline:8911451 doi:10.1111/j.1365-3156.1996.tb00092.x
35. +
Özen Tunay
Z, Ozdemir
O, Petricli
IS. Povidone iodine in the treatment of adenoviral conjunctivitis in infants. Cutan Ocul Toxicol. 2015;34(1):12–15. Medline:24678746 doi:10.3109/15569527.2014.888077
36. +
Patel
PB, Diaz
MC, Bennett
JE, Attia
MW. Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007;14(1):1–5. Medline:17119185 doi:10.1197/j.aem.2006.08.006
37. +
Pinto
RD, Lira
RP, Abe
RY,
et al. Dexamethasone/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res. 2015;40(9):870–877. Medline:25310347 doi:10.3109/02713683.2014.964419
38. +
Pinto
RD, Lira
RP, Arieta
CE, Castro
RS, Bonon
SH. The
prevalence of adenoviral conjunctivitis at the Clinical Hospital of the State University of Campinas, Brazil.
Clinics (Sao Paulo). 2015;70(11):748–750. Medline:26602522 doi:10.6061/clinics/2015(11)06
39. +
Rose
PW, Harnden
A, Brueggemann
AB,
et al. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9479):37–43. Medline:15993231 doi:10.1016/S0140-6736(05)66709-8
40. +
Sambursky
R, Tauber
S, Schirra
F, Kozich
K, Davidson
R, Cohen
EJ. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology. 2006;113(10):1758–1764. Medline:17011956 doi:10.1016/j.ophtha.2006.06.029
41. +
Sambursky
R, Trattler
W, Tauber
S,
et al.
Sensitivity and
specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis.
JAMA Ophthalmol. 2013;131(1):17–22. Medline:23307204 doi:10.1001/2013.jamaophthalmol.513
42. +
Shiuey
Y, Ambati
BK, Adamis
AP. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology. 2000;107(8):1512–1517. Medline:10919900 doi:10.1016/S0161-6420(00)00177-9
43. +
Tabbara
KF, Omar
N, Hammouda
E,
et al. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia.
Mol Vis. 2010;16:2132–2136. Medline:21139691
[PubMed: 21139691]
44. +
van Weert
HC, Tellegen
E, Ter Riet
G. A new diagnostic index for bacterial conjunctivitis in primary care: a re-derivation study. Eur J Gen Pract. 2014;20(3):202–208. Medline:24256320 doi:10.3109/13814788.2013.842970
45. +
Weiss
A, Brinser
JH, Nazar-Stewart
V. Acute conjunctivitis in childhood. J Pediatr. 1993;122(1):10–14. Medline:8419593 doi:10.1016/S0022-3476(05)83479-1
46. +
Wilkins
MR, Khan
S, Bunce
C, Khawaja
A, Siriwardena
D, Larkin
DF. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol. 2011;95(9):1299–1303. Medline:21252084 doi:10.1136/bjo.2010.188623
47. +
Woodland
RM, Darougar
S, Thaker
U,
et al. Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan. Trans R Soc Trop Med Hyg. 1992;86(3):317–320. Medline:1412664 doi:10.1016/0035-9203(92)90328-A
48. +
Heindl
LM, Augustin
AJ, Messmer
EM; ADVISE study group. ADenoVirus Initiative Study in Epidemiology (ADVISE)—results of a multicenter epidemiology study in Germany. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):249–251. Medline:30255398 doi:10.1007/s00417-018-4150-2
49. +
Li
D, Zhou
JN, Li
H,
et al. An outbreak of epidemic keratoconjunctivitis caused by human adenovirus type 8 in primary school, southwest China. BMC Infect Dis. 2019;19(1):624. Medline:31307413 doi:10.1186/s12879-019-4232-8
50. +
Sheikh
A, Hurwitz
B, van Schayck
CP, McLean
S, Nurmatov
U. Antibiotics versus
placebo for acute bacterial conjunctivitis.
Cochrane Database Syst Rev. 2012;(9):CD001211. Medline:22972049 doi:10.1002/14651858.CD001211.pub3
51. +
Yamadera
S, Yamashita
K, Akatsuka
M,
et al. Adenovirus surveillance, 1982-1993, Japan: a report of the national epidemiological surveillance of infectious agents in Japan. Jpn J Med Sci Biol. 1995;48(4):199–210. Medline:8569045 doi:10.7883/yoken1952.48.199
53. +
Kaneko
H, Aoki
K, Ishida
S,
et al. Recombination analysis of intermediate human adenovirus type 53 in Japan by complete
genome sequence.
J Gen Virol. 2011;92(pt 6):1251–1259. Medline:21402595 doi:10.1099/vir.0.030361-0
54. +
Zhang
L, Zhao
N, Sha
J,
et al. Virology and epidemiology analyses of global adenovirus–associated conjunctivitis outbreaks, 1953-2013. Epidemiol Infect. 2016;144(8):1661–1672. Medline:26732024 doi:10.1017/S0950268815003246
55. +
Roggen
I, van Berlaer
G, Gordts
F, Pierard
D, Hubloue
I. Centor criteria in children in a paediatric emergency department: for what it is worth. BMJ Open. 2013;3(4):e002712. Medline:23613571 doi:10.1136/bmjopen-2013-002712